Hartmut Goldschmidt

Statistics

Publications

Citations

263

H-Index

Active since

2024

Affiliations

Universität Hamburg(Current)

Hartmut Goldschmidt is an author at Universität Hamburg specializing in hematologic malignancy therapy, multiple myeloma therapy, and multiple myeloma.

Publications per year

2024–2024

Publications

Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Thierry Façon, Meletios Α. Dimopoulos, Xavier P Leleu et al. · New England Journal of Medicine · 2024 · 243 citations

Pharmacy, Hematology, Pharmacotherapy +16

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial

Hartmut Goldschmidt, Kaya Miah, Uta Bertsch et al. · The Lancet Haematology · 2024 · 20 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

1–2 of 2